Patent details

EP3528812 Title: PALBOCICLIB FOR TREATING PAH

Basic Information

Publication number:
EP3528812
PCT Application Number:
IB2017056226
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP177870292
PCT Publication Number:
WO2018073687
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
PALBOCICLIB FOR TREATING PAH
French Title of Invention:
PALBOCICLIB POUR LE TRAITEMENT DE LA HTAP
German Title of Invention:
PALBOCICLIB ZUR BEHANDLUNG VON PAH
SPC Number:

Dates

Filing date:
09/10/2017
Grant date:
30/12/2020
EP Publication Date:
28/08/2019
PCT Publication Date:
26/04/2018
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
30/12/2020
EP B1 Publication Date:
30/12/2020
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
09/10/2021
Expiration date:
09/10/2037
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
23/12/2020
 
 

Name:
Pfizer Inc.
Address:
235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

Name:
EVANS, Steven Martin
Address:
United States (US)

Priority

1

Priority Number:
201662410566 P
Priority Date:
20/10/2016
Priority Country:
United States (US)

2

Priority Number:
201762548629 P
Priority Date:
22/08/2017
Priority Country:
United States (US)

Classification

IPC classification:
A61K 31/519; A61K 45/06; A61P 11/00;

Publication

European Patent Bulletin

Issue number:
202053
Publication date:
30/12/2020
Description:
Grant (B1)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages